Abdominal wall reconstruction
For many years, recurrence rate has been the gauge of success in hernia repair. However, in challenging hernias - which account for more than 50% of all ventral hernia repairs - management of infection risk is another key measurement of success. Risk varies from patient to patient and that is why effectively assessing risk of infection can be directly correlated to optimizing outcomes and minimizing complications. In an effort to develop a framework for gauging hernia infection risk, LifeCell, in conjunction with surgeon consultants, developed the Hernia Grading System.
*Developed by LifeCell in conjunction with surgeon consultants
Soft-tissue repair materials that revascularize while providing strong repair hold promise for patients with challenging hernias.
LifeCell™ Tissue Matrices, AlloDerm® Regenerative Tissue Matrix and Strattice™ Reconstructive Tissue Matrix, undergo non-damaging proprietary processing resulting in intact, acellular matrices that are strong and support regeneration by way of rapid revascularization, as shown in an animal model.
*Data on file.
Before use, physicians should review all risk information and essential prescribing information which can be found in the Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix Instructions for Use. Physicians should also refer to the Instructions for Use for detailed preparation and implantation instructions.
AlloDerm® Regenerative Tissue Matrix Abdominal Wall reconstruction
Strattice™ Reconstructive Tissue Matrix Abdominal Wall reconstruction